1. The Influence of Human Astrocyte-Conditioned Media on Glioblastoma Multiforme Response to Temozolomide and Bay 11-7082
   Sadaf E. Pustchi et al, 2022, IEEE Access CrossRef
2. Evaluation of Cytotoxic Activity of Betanin Against U87MG Human Glioma Cells and Normal Human Lymphocytes and Its Anticancer Potential Through Mitochondrial Pathway
   Ahmad Salimi et al, 2021, Nutrition and Cancer CrossRef
3. Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells
   José E. Vargas et al, 2014, Biochemistry and Cell Biology CrossRef
4. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion
   Andrea J. Yool et al, 2020, Frontiers in Pharmacology CrossRef
5. Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation
   Megha Jhanji et al, 2021, GeroScience CrossRef
6. Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells
   Eric Neuhaus et al, 2019, Cancers CrossRef
7. Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths
   Sepideh Karkon-Shayan et al, 2023, Acta Histochemica CrossRef
8. The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
   Terezia Kiskova et al, 2020, Biomolecules CrossRef
9. Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells
   Raffaela Silvestre Ignarro et al, 2016, Molecular and Cellular Biochemistry CrossRef
10. Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
    Veronica Cocetta et al, 2021, International Journal of Molecular Sciences CrossRef
11. Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action
    Annielle Mendes Brito da Silva et al, 2018, Molecular Neurobiology CrossRef
12. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
    Xanthene Miles et al, 2021, Frontiers in Oncology CrossRef
13. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
    Francesca Lombardi et al, 2022, International Journal of Molecular Sciences CrossRef
14. Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
    Md. Sahab Uddin et al, 2021, Frontiers in Pharmacology CrossRef
15. Role of selected MGMT polymorphisms in cancer development
    Paweł Kiczmer et al, 2017, Annales Academiae Medicae Silesiensis CrossRef
16. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
    Mariana Medeiros et al, 2021, Cellular and Molecular Life Sciences CrossRef
17. Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
    Stephanie Andrade et al, 2018, Frontiers in Pharmacology CrossRef
18. Role of Ayurvedic Plants as Anticancer Agents
    Nikhil Pandey et al, 2022, Medulloblastoma CrossRef
19. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
    Sajad Fakhri et al, 2022, Frontiers in Oncology CrossRef
20. Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells
    Francisco Alejandro Lagunas-Rangel et al, 2020, Frontiers in Oncology CrossRef
21. Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells
    Md. Ataur Rahman et al, 2020, Frontiers in Cell and Developmental Biology CrossRef